Belbuca Film, Soluble
NDC Package 59385-024-60
Package Information
Belbuca (buprenorphine hydrochloride) films is buprenorphine is used to help relieve severe ongoing pain. This formulation utilizes a film, soluble delivery system. Marketed by Biodelivery Sciences International Inc, this product is identified by NDC 59385-024 and is authorized under FDA application NDA207932.
Identification & Billing
- RxCUI: 1716057 - buprenorphine HCl 150 MCG Buccal Film
- RxCUI: 1716057 - buprenorphine 0.15 MG Buccal Film
- RxCUI: 1716063 - Belbuca 150 MCG Buccal Film
- RxCUI: 1716063 - buprenorphine 0.15 MG Buccal Film [Belbuca]
- RxCUI: 1716063 - Belbuca 0.15 MG (as buprenorphine HCl) Buccal Film
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 59385 - Biodelivery Sciences International Inc
- 59385-024 - Belbuca
- 59385-024-60 - 60 POUCH in 1 CARTON / 1 FILM, SOLUBLE in 1 POUCH (59385-024-01)
- 59385-024 - Belbuca
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59385-024-60 identifies a specific commercial package of 60 pouch in 1 carton / 1 film, soluble in 1 pouch (59385-024-01) of Belbuca, a human prescription drug labeled by Biodelivery Sciences International Inc. This film, soluble is formulated for buccal use and contains buprenorphine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Biodelivery Sciences International Inc on August 21, 2017. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Buprenorphine is used to help relieve severe ongoing pain. Buprenorphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. Do not use this medication to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use.
How is this Biodelivery Sciences International Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59385002460. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.